nodes	percent_of_prediction	percent_of_DWPC	metapath
Imipramine—ABCB1—Methylprednisolone—ankylosing spondylitis	0.065	0.0943	CbGbCtD
Imipramine—CYP3A7—Dexamethasone—ankylosing spondylitis	0.0504	0.073	CbGbCtD
Imipramine—CYP3A7-CYP3A51P—Dexamethasone—ankylosing spondylitis	0.0504	0.073	CbGbCtD
Imipramine—CYP2C19—Prednisone—ankylosing spondylitis	0.0488	0.0708	CbGbCtD
Imipramine—CYP2E1—Dexamethasone—ankylosing spondylitis	0.0486	0.0705	CbGbCtD
Imipramine—CYP2B6—Dexamethasone—ankylosing spondylitis	0.048	0.0695	CbGbCtD
Imipramine—ABCB1—Betamethasone—ankylosing spondylitis	0.0423	0.0613	CbGbCtD
Imipramine—ABCB1—Prednisolone—ankylosing spondylitis	0.0417	0.0605	CbGbCtD
Imipramine—ABCB1—Prednisone—ankylosing spondylitis	0.0394	0.0571	CbGbCtD
Imipramine—CYP3A4—Methylprednisolone—ankylosing spondylitis	0.039	0.0565	CbGbCtD
Imipramine—CYP2C19—Dexamethasone—ankylosing spondylitis	0.0305	0.0442	CbGbCtD
Imipramine—CYP3A4—Triamcinolone—ankylosing spondylitis	0.0295	0.0428	CbGbCtD
Imipramine—CYP3A4—Betamethasone—ankylosing spondylitis	0.0253	0.0367	CbGbCtD
Imipramine—CYP3A4—Prednisolone—ankylosing spondylitis	0.025	0.0362	CbGbCtD
Imipramine—ABCB1—Dexamethasone—ankylosing spondylitis	0.0246	0.0357	CbGbCtD
Imipramine—CYP3A4—Prednisone—ankylosing spondylitis	0.0236	0.0342	CbGbCtD
Imipramine—CYP2D6—Dexamethasone—ankylosing spondylitis	0.0232	0.0336	CbGbCtD
Imipramine—ABCB1—Methotrexate—ankylosing spondylitis	0.0198	0.0287	CbGbCtD
Imipramine—CYP3A4—Dexamethasone—ankylosing spondylitis	0.0147	0.0214	CbGbCtD
Imipramine—Anaphylactic shock—Prednisolone—ankylosing spondylitis	0.000603	0.00195	CcSEcCtD
Imipramine—Oedema—Prednisolone—ankylosing spondylitis	0.000603	0.00195	CcSEcCtD
Imipramine—Loss of consciousness—Triamcinolone—ankylosing spondylitis	0.000598	0.00193	CcSEcCtD
Imipramine—Loss of consciousness—Methylprednisolone—ankylosing spondylitis	0.000596	0.00192	CcSEcCtD
Imipramine—Shock—Prednisolone—ankylosing spondylitis	0.000594	0.00192	CcSEcCtD
Imipramine—Erectile dysfunction—Methotrexate—ankylosing spondylitis	0.000594	0.00191	CcSEcCtD
Imipramine—Convulsion—Triamcinolone—ankylosing spondylitis	0.000589	0.0019	CcSEcCtD
Imipramine—Tachycardia—Prednisolone—ankylosing spondylitis	0.000589	0.0019	CcSEcCtD
Imipramine—Photosensitivity reaction—Methotrexate—ankylosing spondylitis	0.000588	0.0019	CcSEcCtD
Imipramine—Convulsion—Methylprednisolone—ankylosing spondylitis	0.000588	0.0019	CcSEcCtD
Imipramine—Hypertension—Triamcinolone—ankylosing spondylitis	0.000587	0.00189	CcSEcCtD
Imipramine—Hypertension—Methylprednisolone—ankylosing spondylitis	0.000586	0.00189	CcSEcCtD
Imipramine—Hyperhidrosis—Prednisolone—ankylosing spondylitis	0.000583	0.00188	CcSEcCtD
Imipramine—Eye disorder—Prednisone—ankylosing spondylitis	0.000577	0.00186	CcSEcCtD
Imipramine—Anxiety—Methylprednisolone—ankylosing spondylitis	0.000576	0.00186	CcSEcCtD
Imipramine—Infestation NOS—Methotrexate—ankylosing spondylitis	0.000575	0.00185	CcSEcCtD
Imipramine—Drowsiness—Methotrexate—ankylosing spondylitis	0.000575	0.00185	CcSEcCtD
Imipramine—Infestation—Methotrexate—ankylosing spondylitis	0.000575	0.00185	CcSEcCtD
Imipramine—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—ankylosing spondylitis	0.000574	0.00185	CcSEcCtD
Imipramine—Flushing—Prednisone—ankylosing spondylitis	0.000573	0.00185	CcSEcCtD
Imipramine—Ill-defined disorder—Dexamethasone—ankylosing spondylitis	0.000572	0.00185	CcSEcCtD
Imipramine—Ill-defined disorder—Betamethasone—ankylosing spondylitis	0.000572	0.00185	CcSEcCtD
Imipramine—Discomfort—Triamcinolone—ankylosing spondylitis	0.000572	0.00185	CcSEcCtD
Imipramine—Discomfort—Methylprednisolone—ankylosing spondylitis	0.000571	0.00184	CcSEcCtD
Imipramine—Dry mouth—Triamcinolone—ankylosing spondylitis	0.000566	0.00183	CcSEcCtD
Imipramine—Stomatitis—Methotrexate—ankylosing spondylitis	0.00056	0.00181	CcSEcCtD
Imipramine—Angiopathy—Prednisone—ankylosing spondylitis	0.00056	0.00181	CcSEcCtD
Imipramine—Confusional state—Methylprednisolone—ankylosing spondylitis	0.000558	0.0018	CcSEcCtD
Imipramine—Immune system disorder—Prednisone—ankylosing spondylitis	0.000557	0.0018	CcSEcCtD
Imipramine—Malaise—Dexamethasone—ankylosing spondylitis	0.000556	0.00179	CcSEcCtD
Imipramine—Malaise—Betamethasone—ankylosing spondylitis	0.000556	0.00179	CcSEcCtD
Imipramine—Anaphylactic shock—Triamcinolone—ankylosing spondylitis	0.000555	0.00179	CcSEcCtD
Imipramine—Oedema—Triamcinolone—ankylosing spondylitis	0.000555	0.00179	CcSEcCtD
Imipramine—Anaphylactic shock—Methylprednisolone—ankylosing spondylitis	0.000554	0.00179	CcSEcCtD
Imipramine—Syncope—Betamethasone—ankylosing spondylitis	0.000553	0.00178	CcSEcCtD
Imipramine—Syncope—Dexamethasone—ankylosing spondylitis	0.000553	0.00178	CcSEcCtD
Imipramine—Arrhythmia—Prednisone—ankylosing spondylitis	0.000551	0.00178	CcSEcCtD
Imipramine—Infection—Triamcinolone—ankylosing spondylitis	0.000551	0.00178	CcSEcCtD
Imipramine—Infection—Methylprednisolone—ankylosing spondylitis	0.00055	0.00177	CcSEcCtD
Imipramine—Shock—Triamcinolone—ankylosing spondylitis	0.000546	0.00176	CcSEcCtD
Imipramine—Insomnia—Prednisolone—ankylosing spondylitis	0.000546	0.00176	CcSEcCtD
Imipramine—Alopecia—Prednisone—ankylosing spondylitis	0.000545	0.00176	CcSEcCtD
Imipramine—Shock—Methylprednisolone—ankylosing spondylitis	0.000545	0.00176	CcSEcCtD
Imipramine—Hepatobiliary disease—Methotrexate—ankylosing spondylitis	0.000543	0.00175	CcSEcCtD
Imipramine—Nervous system disorder—Methylprednisolone—ankylosing spondylitis	0.000543	0.00175	CcSEcCtD
Imipramine—Loss of consciousness—Betamethasone—ankylosing spondylitis	0.000542	0.00175	CcSEcCtD
Imipramine—Loss of consciousness—Dexamethasone—ankylosing spondylitis	0.000542	0.00175	CcSEcCtD
Imipramine—Paraesthesia—Prednisolone—ankylosing spondylitis	0.000542	0.00175	CcSEcCtD
Imipramine—Tachycardia—Triamcinolone—ankylosing spondylitis	0.000542	0.00175	CcSEcCtD
Imipramine—Mental disorder—Prednisone—ankylosing spondylitis	0.000541	0.00174	CcSEcCtD
Imipramine—Tachycardia—Methylprednisolone—ankylosing spondylitis	0.00054	0.00174	CcSEcCtD
Imipramine—Skin disorder—Methylprednisolone—ankylosing spondylitis	0.000538	0.00173	CcSEcCtD
Imipramine—Malnutrition—Prednisone—ankylosing spondylitis	0.000537	0.00173	CcSEcCtD
Imipramine—Hyperhidrosis—Triamcinolone—ankylosing spondylitis	0.000536	0.00173	CcSEcCtD
Imipramine—Agranulocytosis—Methotrexate—ankylosing spondylitis	0.000536	0.00173	CcSEcCtD
Imipramine—Hyperhidrosis—Methylprednisolone—ankylosing spondylitis	0.000535	0.00173	CcSEcCtD
Imipramine—Convulsion—Betamethasone—ankylosing spondylitis	0.000535	0.00172	CcSEcCtD
Imipramine—Convulsion—Dexamethasone—ankylosing spondylitis	0.000535	0.00172	CcSEcCtD
Imipramine—Hypertension—Dexamethasone—ankylosing spondylitis	0.000533	0.00172	CcSEcCtD
Imipramine—Hypertension—Betamethasone—ankylosing spondylitis	0.000533	0.00172	CcSEcCtD
Imipramine—Anxiety—Dexamethasone—ankylosing spondylitis	0.000523	0.00169	CcSEcCtD
Imipramine—Anxiety—Betamethasone—ankylosing spondylitis	0.000523	0.00169	CcSEcCtD
Imipramine—Discomfort—Betamethasone—ankylosing spondylitis	0.000519	0.00167	CcSEcCtD
Imipramine—Discomfort—Dexamethasone—ankylosing spondylitis	0.000519	0.00167	CcSEcCtD
Imipramine—Hepatitis—Methotrexate—ankylosing spondylitis	0.000516	0.00166	CcSEcCtD
Imipramine—Urinary tract disorder—Methotrexate—ankylosing spondylitis	0.000509	0.00164	CcSEcCtD
Imipramine—Vision blurred—Prednisone—ankylosing spondylitis	0.000506	0.00163	CcSEcCtD
Imipramine—Urethral disorder—Methotrexate—ankylosing spondylitis	0.000506	0.00163	CcSEcCtD
Imipramine—Oedema—Dexamethasone—ankylosing spondylitis	0.000504	0.00162	CcSEcCtD
Imipramine—Anaphylactic shock—Betamethasone—ankylosing spondylitis	0.000504	0.00162	CcSEcCtD
Imipramine—Anaphylactic shock—Dexamethasone—ankylosing spondylitis	0.000504	0.00162	CcSEcCtD
Imipramine—Oedema—Betamethasone—ankylosing spondylitis	0.000504	0.00162	CcSEcCtD
Imipramine—Insomnia—Triamcinolone—ankylosing spondylitis	0.000502	0.00162	CcSEcCtD
Imipramine—Insomnia—Methylprednisolone—ankylosing spondylitis	0.000501	0.00162	CcSEcCtD
Imipramine—Infection—Betamethasone—ankylosing spondylitis	0.0005	0.00161	CcSEcCtD
Imipramine—Infection—Dexamethasone—ankylosing spondylitis	0.0005	0.00161	CcSEcCtD
Imipramine—Ill-defined disorder—Prednisone—ankylosing spondylitis	0.000498	0.00161	CcSEcCtD
Imipramine—Paraesthesia—Triamcinolone—ankylosing spondylitis	0.000498	0.00161	CcSEcCtD
Imipramine—Feeling abnormal—Prednisolone—ankylosing spondylitis	0.000497	0.0016	CcSEcCtD
Imipramine—Paraesthesia—Methylprednisolone—ankylosing spondylitis	0.000497	0.0016	CcSEcCtD
Imipramine—Shock—Dexamethasone—ankylosing spondylitis	0.000495	0.0016	CcSEcCtD
Imipramine—Shock—Betamethasone—ankylosing spondylitis	0.000495	0.0016	CcSEcCtD
Imipramine—Nervous system disorder—Dexamethasone—ankylosing spondylitis	0.000494	0.00159	CcSEcCtD
Imipramine—Nervous system disorder—Betamethasone—ankylosing spondylitis	0.000494	0.00159	CcSEcCtD
Imipramine—Agitation—Prednisone—ankylosing spondylitis	0.000494	0.00159	CcSEcCtD
Imipramine—Thrombocytopenia—Dexamethasone—ankylosing spondylitis	0.000493	0.00159	CcSEcCtD
Imipramine—Thrombocytopenia—Betamethasone—ankylosing spondylitis	0.000493	0.00159	CcSEcCtD
Imipramine—Tachycardia—Betamethasone—ankylosing spondylitis	0.000491	0.00159	CcSEcCtD
Imipramine—Tachycardia—Dexamethasone—ankylosing spondylitis	0.000491	0.00159	CcSEcCtD
Imipramine—Dyspepsia—Triamcinolone—ankylosing spondylitis	0.000488	0.00158	CcSEcCtD
Imipramine—Dyspepsia—Methylprednisolone—ankylosing spondylitis	0.000487	0.00157	CcSEcCtD
Imipramine—Hyperhidrosis—Betamethasone—ankylosing spondylitis	0.000487	0.00157	CcSEcCtD
Imipramine—Hyperhidrosis—Dexamethasone—ankylosing spondylitis	0.000487	0.00157	CcSEcCtD
Imipramine—Malaise—Prednisone—ankylosing spondylitis	0.000485	0.00156	CcSEcCtD
Imipramine—Eye disorder—Methotrexate—ankylosing spondylitis	0.000482	0.00156	CcSEcCtD
Imipramine—Syncope—Prednisone—ankylosing spondylitis	0.000482	0.00155	CcSEcCtD
Imipramine—Tinnitus—Methotrexate—ankylosing spondylitis	0.000481	0.00155	CcSEcCtD
Imipramine—Anorexia—Betamethasone—ankylosing spondylitis	0.00048	0.00155	CcSEcCtD
Imipramine—Anorexia—Dexamethasone—ankylosing spondylitis	0.00048	0.00155	CcSEcCtD
Imipramine—Urticaria—Prednisolone—ankylosing spondylitis	0.000479	0.00155	CcSEcCtD
Imipramine—Cardiac disorder—Methotrexate—ankylosing spondylitis	0.000479	0.00154	CcSEcCtD
Imipramine—Fatigue—Triamcinolone—ankylosing spondylitis	0.000478	0.00154	CcSEcCtD
Imipramine—Fatigue—Methylprednisolone—ankylosing spondylitis	0.000477	0.00154	CcSEcCtD
Imipramine—Loss of consciousness—Prednisone—ankylosing spondylitis	0.000472	0.00152	CcSEcCtD
Imipramine—Angiopathy—Methotrexate—ankylosing spondylitis	0.000468	0.00151	CcSEcCtD
Imipramine—Immune system disorder—Methotrexate—ankylosing spondylitis	0.000466	0.0015	CcSEcCtD
Imipramine—Convulsion—Prednisone—ankylosing spondylitis	0.000466	0.0015	CcSEcCtD
Imipramine—Mediastinal disorder—Methotrexate—ankylosing spondylitis	0.000465	0.0015	CcSEcCtD
Imipramine—Hypertension—Prednisone—ankylosing spondylitis	0.000464	0.0015	CcSEcCtD
Imipramine—Feeling abnormal—Triamcinolone—ankylosing spondylitis	0.000457	0.00148	CcSEcCtD
Imipramine—Feeling abnormal—Methylprednisolone—ankylosing spondylitis	0.000456	0.00147	CcSEcCtD
Imipramine—Anxiety—Prednisone—ankylosing spondylitis	0.000456	0.00147	CcSEcCtD
Imipramine—Alopecia—Methotrexate—ankylosing spondylitis	0.000456	0.00147	CcSEcCtD
Imipramine—Insomnia—Betamethasone—ankylosing spondylitis	0.000455	0.00147	CcSEcCtD
Imipramine—Insomnia—Dexamethasone—ankylosing spondylitis	0.000455	0.00147	CcSEcCtD
Imipramine—Unspecified disorder of skin and subcutaneous tissue—Prednisone—ankylosing spondylitis	0.000454	0.00147	CcSEcCtD
Imipramine—Gastrointestinal pain—Methylprednisolone—ankylosing spondylitis	0.000453	0.00146	CcSEcCtD
Imipramine—Paraesthesia—Betamethasone—ankylosing spondylitis	0.000452	0.00146	CcSEcCtD
Imipramine—Paraesthesia—Dexamethasone—ankylosing spondylitis	0.000452	0.00146	CcSEcCtD
Imipramine—Discomfort—Prednisone—ankylosing spondylitis	0.000452	0.00146	CcSEcCtD
Imipramine—Mental disorder—Methotrexate—ankylosing spondylitis	0.000452	0.00146	CcSEcCtD
Imipramine—Malnutrition—Methotrexate—ankylosing spondylitis	0.000449	0.00145	CcSEcCtD
Imipramine—Dyspepsia—Dexamethasone—ankylosing spondylitis	0.000443	0.00143	CcSEcCtD
Imipramine—Dyspepsia—Betamethasone—ankylosing spondylitis	0.000443	0.00143	CcSEcCtD
Imipramine—Urticaria—Triamcinolone—ankylosing spondylitis	0.000441	0.00142	CcSEcCtD
Imipramine—Urticaria—Methylprednisolone—ankylosing spondylitis	0.00044	0.00142	CcSEcCtD
Imipramine—Dysgeusia—Methotrexate—ankylosing spondylitis	0.00044	0.00142	CcSEcCtD
Imipramine—Body temperature increased—Triamcinolone—ankylosing spondylitis	0.000439	0.00142	CcSEcCtD
Imipramine—Oedema—Prednisone—ankylosing spondylitis	0.000438	0.00141	CcSEcCtD
Imipramine—Anaphylactic shock—Prednisone—ankylosing spondylitis	0.000438	0.00141	CcSEcCtD
Imipramine—Abdominal pain—Methylprednisolone—ankylosing spondylitis	0.000438	0.00141	CcSEcCtD
Imipramine—Decreased appetite—Dexamethasone—ankylosing spondylitis	0.000438	0.00141	CcSEcCtD
Imipramine—Decreased appetite—Betamethasone—ankylosing spondylitis	0.000438	0.00141	CcSEcCtD
Imipramine—Infection—Prednisone—ankylosing spondylitis	0.000436	0.00141	CcSEcCtD
Imipramine—Gastrointestinal disorder—Dexamethasone—ankylosing spondylitis	0.000435	0.0014	CcSEcCtD
Imipramine—Gastrointestinal disorder—Betamethasone—ankylosing spondylitis	0.000435	0.0014	CcSEcCtD
Imipramine—Fatigue—Dexamethasone—ankylosing spondylitis	0.000434	0.0014	CcSEcCtD
Imipramine—Fatigue—Betamethasone—ankylosing spondylitis	0.000434	0.0014	CcSEcCtD
Imipramine—Shock—Prednisone—ankylosing spondylitis	0.000431	0.00139	CcSEcCtD
Imipramine—Nervous system disorder—Prednisone—ankylosing spondylitis	0.00043	0.00139	CcSEcCtD
Imipramine—Tachycardia—Prednisone—ankylosing spondylitis	0.000428	0.00138	CcSEcCtD
Imipramine—Skin disorder—Prednisone—ankylosing spondylitis	0.000426	0.00137	CcSEcCtD
Imipramine—Hyperhidrosis—Prednisone—ankylosing spondylitis	0.000424	0.00137	CcSEcCtD
Imipramine—Vision blurred—Methotrexate—ankylosing spondylitis	0.000423	0.00137	CcSEcCtD
Imipramine—Anorexia—Prednisone—ankylosing spondylitis	0.000418	0.00135	CcSEcCtD
Imipramine—Ill-defined disorder—Methotrexate—ankylosing spondylitis	0.000417	0.00134	CcSEcCtD
Imipramine—Feeling abnormal—Betamethasone—ankylosing spondylitis	0.000415	0.00134	CcSEcCtD
Imipramine—Feeling abnormal—Dexamethasone—ankylosing spondylitis	0.000415	0.00134	CcSEcCtD
Imipramine—Gastrointestinal pain—Dexamethasone—ankylosing spondylitis	0.000412	0.00133	CcSEcCtD
Imipramine—Gastrointestinal pain—Betamethasone—ankylosing spondylitis	0.000412	0.00133	CcSEcCtD
Imipramine—Malaise—Methotrexate—ankylosing spondylitis	0.000405	0.00131	CcSEcCtD
Imipramine—Leukopenia—Methotrexate—ankylosing spondylitis	0.000402	0.0013	CcSEcCtD
Imipramine—Urticaria—Dexamethasone—ankylosing spondylitis	0.0004	0.00129	CcSEcCtD
Imipramine—Urticaria—Betamethasone—ankylosing spondylitis	0.0004	0.00129	CcSEcCtD
Imipramine—Dizziness—Prednisolone—ankylosing spondylitis	0.000399	0.00129	CcSEcCtD
Imipramine—Asthenia—Triamcinolone—ankylosing spondylitis	0.000398	0.00128	CcSEcCtD
Imipramine—Body temperature increased—Dexamethasone—ankylosing spondylitis	0.000398	0.00128	CcSEcCtD
Imipramine—Abdominal pain—Betamethasone—ankylosing spondylitis	0.000398	0.00128	CcSEcCtD
Imipramine—Body temperature increased—Betamethasone—ankylosing spondylitis	0.000398	0.00128	CcSEcCtD
Imipramine—Abdominal pain—Dexamethasone—ankylosing spondylitis	0.000398	0.00128	CcSEcCtD
Imipramine—Asthenia—Methylprednisolone—ankylosing spondylitis	0.000397	0.00128	CcSEcCtD
Imipramine—Insomnia—Prednisone—ankylosing spondylitis	0.000397	0.00128	CcSEcCtD
Imipramine—Paraesthesia—Prednisone—ankylosing spondylitis	0.000394	0.00127	CcSEcCtD
Imipramine—Pruritus—Triamcinolone—ankylosing spondylitis	0.000393	0.00127	CcSEcCtD
Imipramine—Pruritus—Methylprednisolone—ankylosing spondylitis	0.000392	0.00126	CcSEcCtD
Imipramine—Convulsion—Methotrexate—ankylosing spondylitis	0.000389	0.00126	CcSEcCtD
Imipramine—Dyspepsia—Prednisone—ankylosing spondylitis	0.000386	0.00125	CcSEcCtD
Imipramine—Decreased appetite—Prednisone—ankylosing spondylitis	0.000381	0.00123	CcSEcCtD
Imipramine—Rash—Prednisolone—ankylosing spondylitis	0.00038	0.00123	CcSEcCtD
Imipramine—Dermatitis—Prednisolone—ankylosing spondylitis	0.00038	0.00123	CcSEcCtD
Imipramine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—ankylosing spondylitis	0.00038	0.00122	CcSEcCtD
Imipramine—Diarrhoea—Methylprednisolone—ankylosing spondylitis	0.000379	0.00122	CcSEcCtD
Imipramine—Fatigue—Prednisone—ankylosing spondylitis	0.000378	0.00122	CcSEcCtD
Imipramine—Headache—Prednisolone—ankylosing spondylitis	0.000378	0.00122	CcSEcCtD
Imipramine—Discomfort—Methotrexate—ankylosing spondylitis	0.000378	0.00122	CcSEcCtD
Imipramine—Constipation—Prednisone—ankylosing spondylitis	0.000375	0.00121	CcSEcCtD
Imipramine—Confusional state—Methotrexate—ankylosing spondylitis	0.000369	0.00119	CcSEcCtD
Imipramine—Dizziness—Triamcinolone—ankylosing spondylitis	0.000367	0.00118	CcSEcCtD
Imipramine—Anaphylactic shock—Methotrexate—ankylosing spondylitis	0.000366	0.00118	CcSEcCtD
Imipramine—Dizziness—Methylprednisolone—ankylosing spondylitis	0.000366	0.00118	CcSEcCtD
Imipramine—Infection—Methotrexate—ankylosing spondylitis	0.000364	0.00117	CcSEcCtD
Imipramine—Feeling abnormal—Prednisone—ankylosing spondylitis	0.000361	0.00117	CcSEcCtD
Imipramine—Asthenia—Betamethasone—ankylosing spondylitis	0.000361	0.00117	CcSEcCtD
Imipramine—Asthenia—Dexamethasone—ankylosing spondylitis	0.000361	0.00117	CcSEcCtD
Imipramine—Nervous system disorder—Methotrexate—ankylosing spondylitis	0.000359	0.00116	CcSEcCtD
Imipramine—Thrombocytopenia—Methotrexate—ankylosing spondylitis	0.000359	0.00116	CcSEcCtD
Imipramine—Gastrointestinal pain—Prednisone—ankylosing spondylitis	0.000359	0.00116	CcSEcCtD
Imipramine—Nausea—Prednisolone—ankylosing spondylitis	0.000358	0.00116	CcSEcCtD
Imipramine—Pruritus—Dexamethasone—ankylosing spondylitis	0.000356	0.00115	CcSEcCtD
Imipramine—Pruritus—Betamethasone—ankylosing spondylitis	0.000356	0.00115	CcSEcCtD
Imipramine—Skin disorder—Methotrexate—ankylosing spondylitis	0.000356	0.00115	CcSEcCtD
Imipramine—Hyperhidrosis—Methotrexate—ankylosing spondylitis	0.000354	0.00114	CcSEcCtD
Imipramine—Vomiting—Triamcinolone—ankylosing spondylitis	0.000353	0.00114	CcSEcCtD
Imipramine—Vomiting—Methylprednisolone—ankylosing spondylitis	0.000352	0.00114	CcSEcCtD
Imipramine—Rash—Triamcinolone—ankylosing spondylitis	0.00035	0.00113	CcSEcCtD
Imipramine—Dermatitis—Triamcinolone—ankylosing spondylitis	0.00035	0.00113	CcSEcCtD
Imipramine—Anorexia—Methotrexate—ankylosing spondylitis	0.000349	0.00113	CcSEcCtD
Imipramine—Rash—Methylprednisolone—ankylosing spondylitis	0.000349	0.00113	CcSEcCtD
Imipramine—Dermatitis—Methylprednisolone—ankylosing spondylitis	0.000349	0.00113	CcSEcCtD
Imipramine—Urticaria—Prednisone—ankylosing spondylitis	0.000348	0.00112	CcSEcCtD
Imipramine—Headache—Triamcinolone—ankylosing spondylitis	0.000348	0.00112	CcSEcCtD
Imipramine—Headache—Methylprednisolone—ankylosing spondylitis	0.000347	0.00112	CcSEcCtD
Imipramine—Abdominal pain—Prednisone—ankylosing spondylitis	0.000347	0.00112	CcSEcCtD
Imipramine—Body temperature increased—Prednisone—ankylosing spondylitis	0.000347	0.00112	CcSEcCtD
Imipramine—Diarrhoea—Dexamethasone—ankylosing spondylitis	0.000344	0.00111	CcSEcCtD
Imipramine—Diarrhoea—Betamethasone—ankylosing spondylitis	0.000344	0.00111	CcSEcCtD
Imipramine—Dizziness—Dexamethasone—ankylosing spondylitis	0.000333	0.00107	CcSEcCtD
Imipramine—Dizziness—Betamethasone—ankylosing spondylitis	0.000333	0.00107	CcSEcCtD
Imipramine—Insomnia—Methotrexate—ankylosing spondylitis	0.000331	0.00107	CcSEcCtD
Imipramine—Nausea—Triamcinolone—ankylosing spondylitis	0.00033	0.00106	CcSEcCtD
Imipramine—Paraesthesia—Methotrexate—ankylosing spondylitis	0.000329	0.00106	CcSEcCtD
Imipramine—Nausea—Methylprednisolone—ankylosing spondylitis	0.000329	0.00106	CcSEcCtD
Imipramine—Somnolence—Methotrexate—ankylosing spondylitis	0.000326	0.00105	CcSEcCtD
Imipramine—Dyspepsia—Methotrexate—ankylosing spondylitis	0.000323	0.00104	CcSEcCtD
Imipramine—Vomiting—Betamethasone—ankylosing spondylitis	0.00032	0.00103	CcSEcCtD
Imipramine—Vomiting—Dexamethasone—ankylosing spondylitis	0.00032	0.00103	CcSEcCtD
Imipramine—Decreased appetite—Methotrexate—ankylosing spondylitis	0.000319	0.00103	CcSEcCtD
Imipramine—Rash—Betamethasone—ankylosing spondylitis	0.000317	0.00102	CcSEcCtD
Imipramine—Rash—Dexamethasone—ankylosing spondylitis	0.000317	0.00102	CcSEcCtD
Imipramine—Dermatitis—Dexamethasone—ankylosing spondylitis	0.000317	0.00102	CcSEcCtD
Imipramine—Dermatitis—Betamethasone—ankylosing spondylitis	0.000317	0.00102	CcSEcCtD
Imipramine—Gastrointestinal disorder—Methotrexate—ankylosing spondylitis	0.000316	0.00102	CcSEcCtD
Imipramine—Fatigue—Methotrexate—ankylosing spondylitis	0.000316	0.00102	CcSEcCtD
Imipramine—Headache—Dexamethasone—ankylosing spondylitis	0.000315	0.00102	CcSEcCtD
Imipramine—Headache—Betamethasone—ankylosing spondylitis	0.000315	0.00102	CcSEcCtD
Imipramine—Asthenia—Prednisone—ankylosing spondylitis	0.000315	0.00101	CcSEcCtD
Imipramine—Pruritus—Prednisone—ankylosing spondylitis	0.00031	0.001	CcSEcCtD
Imipramine—Feeling abnormal—Methotrexate—ankylosing spondylitis	0.000302	0.000974	CcSEcCtD
Imipramine—Diarrhoea—Prednisone—ankylosing spondylitis	0.0003	0.000968	CcSEcCtD
Imipramine—Gastrointestinal pain—Methotrexate—ankylosing spondylitis	0.0003	0.000967	CcSEcCtD
Imipramine—Nausea—Betamethasone—ankylosing spondylitis	0.000299	0.000965	CcSEcCtD
Imipramine—Nausea—Dexamethasone—ankylosing spondylitis	0.000299	0.000965	CcSEcCtD
Imipramine—Urticaria—Methotrexate—ankylosing spondylitis	0.000291	0.000939	CcSEcCtD
Imipramine—Dizziness—Prednisone—ankylosing spondylitis	0.00029	0.000935	CcSEcCtD
Imipramine—Abdominal pain—Methotrexate—ankylosing spondylitis	0.00029	0.000935	CcSEcCtD
Imipramine—Body temperature increased—Methotrexate—ankylosing spondylitis	0.00029	0.000935	CcSEcCtD
Imipramine—Vomiting—Prednisone—ankylosing spondylitis	0.000279	0.000899	CcSEcCtD
Imipramine—Rash—Prednisone—ankylosing spondylitis	0.000276	0.000892	CcSEcCtD
Imipramine—Dermatitis—Prednisone—ankylosing spondylitis	0.000276	0.000891	CcSEcCtD
Imipramine—Headache—Prednisone—ankylosing spondylitis	0.000275	0.000886	CcSEcCtD
Imipramine—Asthenia—Methotrexate—ankylosing spondylitis	0.000263	0.000848	CcSEcCtD
Imipramine—Nausea—Prednisone—ankylosing spondylitis	0.00026	0.00084	CcSEcCtD
Imipramine—Pruritus—Methotrexate—ankylosing spondylitis	0.000259	0.000836	CcSEcCtD
Imipramine—Diarrhoea—Methotrexate—ankylosing spondylitis	0.000251	0.000809	CcSEcCtD
Imipramine—Dizziness—Methotrexate—ankylosing spondylitis	0.000242	0.000782	CcSEcCtD
Imipramine—Vomiting—Methotrexate—ankylosing spondylitis	0.000233	0.000752	CcSEcCtD
Imipramine—Rash—Methotrexate—ankylosing spondylitis	0.000231	0.000745	CcSEcCtD
Imipramine—Dermatitis—Methotrexate—ankylosing spondylitis	0.000231	0.000745	CcSEcCtD
Imipramine—Headache—Methotrexate—ankylosing spondylitis	0.00023	0.000741	CcSEcCtD
Imipramine—Nausea—Methotrexate—ankylosing spondylitis	0.000218	0.000702	CcSEcCtD
